PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

After Great Dane success, cancer doc eyes brain tumors

2 University of Colorado Cancer Center publications set stage for K9 cancer vaccine test with human glioblastoma

2013-06-28
(Press-News.org) Michael Graner, PhD, is a CU Cancer Center investigator and associate professor of neurosurgery at the CU School of Medicine. So when his 12-year-old Great Dane got sick, he knew what to do.

"We got Star from the Mid-Atlantic Great Dane Rescue," Graner says. "She got her name because she was always smiling, like a movie star waiting for photos. She'd already been to so many shelters, we didn't want to change her name again and so we kept it."

At 12, after many years with the Graners, Star had already reached about double the average lifespan for the breed. When she collapsed during a coughing fit, Graner discovered the cause: lung cancer, specifically advanced bronchoalveolar adenocarcinoma with metastasis to the lymph nodes. The prognosis was grim, with a median survival from diagnosis of only about 6-27 days. And Star was well past the age when she could've tolerated chemotherapy or radiation.

"With that diagnosis, chemotherapy has only a 10-15 percent response rate and she was old – with her prognosis and the drug side effects let's just say chemotherapy wasn't viable. We didn't want to make her any sicker," Graner says.

So he turned to his specialty, immunotherapy. The idea is to circumvent the immune system's nasty habit of recognizing cancer as its own tissue instead of seeing it as an invading disease and attacking it. By using engineered vaccines to prime the immune system to recognize tumors, cancer immunologists are using the body's own defenses to clear itself of the disease. In this case, the treatment was fairly simple and carried almost no chance of side effects that could make Star any less comfortable: a 10-gram sample of her tumor was enriched into an injectable vaccine that contained a high concentration of heat shock proteins in "chaperone-rich cell lysate" (CRCL), which tell the immune system's T-cells what to attack.

"We expected to see solid metastases within days," said Graner. "But, you know, then the months started to go by. The important thing to us was her quality of life was really good. It was really simple and it certainly didn't hurt." You can read about the treatment and results in a paper in the International Journal of Hyperthermia, on which Graner collaborated with Laura Epple, DVM, now a PhD candidate in the Graner Lab.

Finally, at 44 weeks – more than ten times the best they should have hoped for! – Star showed aggressive progression of the disease. At nearly a year after the diagnosis of a disease that should have killed her within a month, Graner and his family made the difficult decision to euthanize Star.

"We still have a couple of her cell lines here in the lab," Graner says. "In that way, she's kind of immortal."

Another chance for Star's immortality comes from her potential for her experience to extend the lives of human brain cancer patients. See, Graner has continued his studies with the CRCL-rich vaccines of the type that led to Star's dramatic and prolonged improvement.

"It's one thing to treat mice in these fake systems and another to treat a naturally arising tumor that had a poor prognosis," Graner says. Along with Kevin Lellehei, chair of Neurosurgery at the University of Colorado School of Medicine, Graner recently submitted a proposal to the FDA to treat human glioblastoma with CRCL vaccine. "Star's success may make it much easier for the FDA to approve similar treatment with human glioblastoma," Graner says.

In Graner's proposed trial, human brain cancer patients would continue to receive the standard of care to treat the disease and would also intersperse treatment with the experimental vaccine, whose benefit he hopes to show, but which is also unlikely to cause additional harm.

He describes a similar protocol that failed to get approval from the European Medicines Agency.

"This isn't a brand new idea," Graner says. "But until now there had been some gaps in our understanding." One of these gaps was the fact that while previous researchers had hypothesized that tumor chaperone proteins carried the peptides that, when enriched and reinjected as a vaccine, could sensitize the immune system to tumor tissues, previous studies hadn't identified these peptides.

In another recent paper, also published in the International Journal of Hyperthermia, Graner describes what he calls, "taking these proteins and beating the peptides off them to see what they are." Sure enough, many of the peptides isolated from tumor samples were derived from proteins unique to cancer – this means that a CRCL vaccine was likely to result in an immune response directed specifically at tumor tissue and not at surrounding, healthy tissues.

Graner writes that, "Parental proteins [that would be targets for the immune cells] are components of major signaling networks of vital importance for cancer cell survival, proliferation, and migration."

With the immune system sensitized, the unique genetic mutations that allow cancer cells to act cancerous would also mark them for destruction. With this research gap filled and with Star demonstrating the vaccine's effect, Graner is hopeful his proposed trial will make it to human patients soon.

"She was a real sweetie," Graner says of Star. "Hopefully her contribution to the world has just begun."



INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

Exotic alloys for potential energy applications

2013-06-28
WASHINGTON D.C., June 28, 2013 -- The search for thermoelectrics, exotic materials that convert heat directly into electricity, has received a boost from researchers at the California Institute of Technology and the University of Tokyo, who have found the best way to identify them. In the new open-access journal APL Materials, the team shows that a relatively simple technique called the "rigid band approximation" can predict a material's properties more accurately than a competing, more complicated method. "The rigid band approach still supplies the simple, predictive ...

Scientists discover thriving colonies of microbes in ocean 'plastisphere'

2013-06-28
Scientists have discovered a diverse multitude of microbes colonizing and thriving on flecks of plastic that have polluted the oceans—a vast new human-made flotilla of microbial communities that they have dubbed the "plastisphere." In a study recently published online in Environmental Science & Technology, the scientists say the plastisphere represents a novel ecological habitat in the ocean and raises a host of questions: How will it change environmental conditions for marine microbes, favoring some that compete with others? How will it change the overall ocean ecosystem ...

Why is pulmonary hypertension at high altitude so common and dangerous?

2013-06-28
New Rochelle, NY, June 26, 2013—Everyone who climbs to high altitude will develop pulmonary hypertension, a temporary constriction of blood vessels that results in increasing strain on the right heart. It is a normal adaptive mechanism but if exaggerated can have serious consequences, resulting in life-threatening disorders and remodeling of the pulmonary circulation. Five mini-Review articles that comprise a Special Topic section in High Altitude Medicine & Biology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers provide an up-to-date overview of the clinical ...

Helping SAD sufferers sleep soundly

2013-06-28
PITTSBURGH—Lying awake in bed plagues everyone occasionally, but for those with seasonal affective disorder, sleeplessness is routine. University of Pittsburgh researchers report in the Journal of Affective Disorders that individuals with seasonal affective disorder (SAD)—a winter depression that leads to loss of motivation and interest in daily activities—have misconceptions about their sleep habits similar to those of insomniacs. These findings open the door for treating seasonal affective disorder similar to the way doctors treat insomnia. Kathryn Roecklein, primary ...

Biochemists identify protease substrates important for bacterial growth and development

2013-06-28
AMHERST, Mass. – Reporting this month in Molecular Microbiology, Peter Chien and colleagues at the University of Massachusetts Amherst describe using a combination of biochemistry and mass spectrometry to "trap" scores of new candidate substrates of the protease ClpXP to reveal how protein degradation is critical to cell cycle progression and bacterial development. The new understanding could lead to identifying new antibiotic targets. As Chien (pronounced Chen) explains, to carry out fundamental life processes such as growing and dividing, cells must orchestrate, in ...

Mapping out how to save species

2013-06-28
In stunning color, new biodiversity research from North Carolina State University maps out priority areas worldwide that hold the key to protecting vulnerable species and focusing conservation efforts. The research, published online in Proceedings of the National Academy of Sciences, pinpoints the highest global concentrations of mammals, amphibians and birds on a scale that's 100 times finer than previous assessments. The findings can be used to make the most of available conservation resources, said Dr. Clinton Jenkins, lead author and research scholar at NC State ...

A second amyloid may play a role in Alzheimer's disease, UC Davis researchers find

2013-06-28
A protein secreted with insulin travels through the bloodstream and accumulates in the brains of individuals with type 2 diabetes and dementia, in the same manner as the amyloid beta Αβ plaques that are associated with Alzheimer's disease, a study by researchers with the UC Davis Alzheimer's Disease Center has found. The study is the first to identify deposits of the protein, called amylin, in the brains of people with Alzheimer's disease, as well as combined deposits of amylin and plaques, suggesting that amylin is a second amyloid as well as a new biomarker ...

Low self-control promotes selfless behavior in close relationships

2013-06-28
When faced with the choice of sacrificing time and energy for a loved one or taking the self-centered route, people's first impulse is to think of others, according to new research published in Psychological Science, a journal of the Association for Psychological Science. "For decades psychologists have assumed that the first impulse is selfish and that it takes self-control to behave in a pro-social manner," says lead researcher Francesca Righetti of VU University Amsterdam in the Netherlands. "We did not believe that this was true in every context, and especially not ...

AIDSVu releases new maps that depict impact of HIV in America

2013-06-28
Today, on National HIV Testing Day, the Rollins School of Public Health at Emory University launched its annual update of AIDSVu, including new interactive online maps that show the latest HIV prevalence data for 20 U.S. cities by ZIP code or census tract. AIDSVu also includes new city snapshots displaying HIV prevalence alongside various social determinants of health – such as poverty, lack of health insurance and educational attainment. AIDSVu -- the most detailed publicly available view of HIV prevalence in the United States -- is a compilation of interactive online ...

Protein is involved with colon cancer cell's ability to invade other cells

2013-06-28
Understanding how the protein km23-1 enables in the spread of colon cancer may lead to new treatments for the disease, according to researchers at Penn State College of Medicine. Previous research shows that km23-1 is involved in the movement of cancer cells and in the control of specific proteins at the leading edge of moving cells. Kathleen Mulder, professor of biochemistry and molecular biology, who discovered the protein, now says km23-1 is used in the cancer cell's ability to move out of a tumor in the early stages of invasion. "km23-1 may be able to help in this ...

LAST 30 PRESS RELEASES:

Neuroscience leader reveals oxytocin's crucial role beyond the 'love hormone' label

Twelve questions to ask your doctor for better brain health in the new year

Microelectronics Science Research Centers to lead charge on next-generation designs and prototypes

Study identifies genetic cause for yellow nail syndrome

New drug to prevent migraine may start working right away

Good news for people with MS: COVID-19 infection not tied to worsening symptoms

Department of Energy announces $179 million for Microelectronics Science Research Centers

Human-related activities continue to threaten global climate and productivity

Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued

Unraveling the power and influence of language

Gene editing tool reduces Alzheimer’s plaque precursor in mice

TNF inhibitors prevent complications in kids with Crohn's disease, recommended as first-line therapies

Twisted Edison: Bright, elliptically polarized incandescent light

Structural cell protein also directly regulates gene transcription

Breaking boundaries: Researchers isolate quantum coherence in classical light systems

Brain map clarifies neuronal connectivity behind motor function

Researchers find compromised indoor air in homes following Marshall Fire

Months after Colorado's Marshall Fire, residents of surviving homes reported health symptoms, poor air quality

Identification of chemical constituents and blood-absorbed components of Shenqi Fuzheng extract based on UPLC-triple-TOF/MS technology

'Glass fences' hinder Japanese female faculty in international research, study finds

Vector winds forecast by numerical weather prediction models still in need of optimization

New research identifies key cellular mechanism driving Alzheimer’s disease

Trends in buprenorphine dispensing among adolescents and young adults in the US

Emergency department physicians vary widely in their likelihood of hospitalizing a patient, even within the same facility

Firearm and motor vehicle pediatric deaths— intersections of age, sex, race, and ethnicity

Association of state cannabis legalization with cannabis use disorder and cannabis poisoning

Gestational hypertension, preeclampsia, and eclampsia and future neurological disorders

Adoption of “hospital-at-home” programs remains concentrated among larger, urban, not-for-profit and academic hospitals

Unlocking the mysteries of the human gut

High-quality nanodiamonds for bioimaging and quantum sensing applications

[Press-News.org] After Great Dane success, cancer doc eyes brain tumors
2 University of Colorado Cancer Center publications set stage for K9 cancer vaccine test with human glioblastoma